ZLY28 is the first-in-class intestinal restricted and orally active FXR and FABP1 dual modulator. ZLY28 also is a novel anti-NASH agent. ZLY28 can be used for the research of nonalcoholic steatohepatitis (NASH)[1].
Molecular Weight:
520.40
CAS Number:
[3004676-77-8]
Formula:
C29H23Cl2NO4
Target:
FXR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
